• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

KIAA0323 Polyklonaler Antikörper

KIAA0323 Polyklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 31461-1-PBS

Synonyme

Protein KHNYN, KHNYN, KH and NYN domain-containing protein

Filter:
  • Western Blot (WB) analysis of various lysates using KIAA0323 Polyclonal antibody (31461-1-AP)

    WB analysis using 31461-1-AP (same clone as 31461-1-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 31461-1-AP (KIAA0323 antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 31461-1-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

31461-1-PBS bindet in WB, Indirect ELISA KIAA0323 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen KIAA0323 fusion protein Ag35413
Vollständiger Name KIAA0323
Beobachtetes Molekulargewicht75 kDa
GenBank-ZugangsnummerBC042554
Gene symbol KIAA0323
Gene ID (NCBI) 23351
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

KIAA0323, also known as KHNYN or KH and NYN domain-containing protein, contains a ribonuclease NYN domain and belongs to the N4BP1 family. The protein is a cofactor for the zinc finger antiviral protein (ZAP protein) which targets viral RNA for degradation and restricts SARS-CoV-2 infection.